Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients
- PMID: 24315439
- DOI: 10.1016/j.stem.2013.11.002
Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients
Abstract
Single murine and human intestinal stem cells can be expanded in culture over long time periods as genetically and phenotypically stable epithelial organoids. Increased cAMP levels induce rapid swelling of such organoids by opening the cystic fibrosis transmembrane conductor receptor (CFTR). This response is lost in organoids derived from cystic fibrosis (CF) patients. Here we use the CRISPR/Cas9 genome editing system to correct the CFTR locus by homologous recombination in cultured intestinal stem cells of CF patients. The corrected allele is expressed and fully functional as measured in clonally expanded organoids. This study provides proof of concept for gene correction by homologous recombination in primary adult stem cells derived from patients with a single-gene hereditary defect.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
CFTR inactivation by lentiviral vector-mediated RNA interference and CRISPR-Cas9 genome editing in human airway epithelial cells.Curr Gene Ther. 2015;15(5):447-59. doi: 10.2174/1566523215666150812115939. Curr Gene Ther. 2015. PMID: 26264708
-
A functional CFTR assay using primary cystic fibrosis intestinal organoids.Nat Med. 2013 Jul;19(7):939-45. doi: 10.1038/nm.3201. Epub 2013 Jun 2. Nat Med. 2013. PMID: 23727931
-
In Vitro Validation of a CRISPR-Mediated CFTR Correction Strategy for Preclinical Translation in Pigs.Hum Gene Ther. 2019 Sep;30(9):1101-1116. doi: 10.1089/hum.2019.074. Epub 2019 Jun 18. Hum Gene Ther. 2019. PMID: 31099266
-
Animal and model systems for studying cystic fibrosis.J Cyst Fibros. 2018 Mar;17(2S):S28-S34. doi: 10.1016/j.jcf.2017.09.001. Epub 2017 Sep 19. J Cyst Fibros. 2018. PMID: 28939349 Free PMC article. Review.
-
CRISPR/Cas 9 genome editing and its applications in organoids.Am J Physiol Gastrointest Liver Physiol. 2017 Mar 1;312(3):G257-G265. doi: 10.1152/ajpgi.00410.2016. Epub 2017 Jan 26. Am J Physiol Gastrointest Liver Physiol. 2017. PMID: 28126704 Review.
Cited by 356 articles
-
Exploiting CRISPR Cas9 in Three-Dimensional Stem Cell Cultures to Model Disease.Front Bioeng Biotechnol. 2020 Jun 24;8:692. doi: 10.3389/fbioe.2020.00692. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32671050 Free PMC article. Review.
-
Human organoids: model systems for human biology and medicine.Nat Rev Mol Cell Biol. 2020 Jul 7:1-14. doi: 10.1038/s41580-020-0259-3. Online ahead of print. Nat Rev Mol Cell Biol. 2020. PMID: 32636524 Free PMC article. Review.
-
Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?Genes (Basel). 2020 Jun 25;11(6):704. doi: 10.3390/genes11060704. Genes (Basel). 2020. PMID: 32630614 Free PMC article. Review.
-
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing.Nat Commun. 2020 Jun 26;11(1):3232. doi: 10.1038/s41467-020-17029-3. Nat Commun. 2020. PMID: 32591530 Free PMC article.
-
Generation of 3D human gastrointestinal organoids: principle and applications.Cell Regen. 2020 Jun 10;9(1):6. doi: 10.1186/s13619-020-00040-w. Cell Regen. 2020. PMID: 32588198 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical